75 related articles for article (PubMed ID: 28283889)
1. CF
Taoka R; Jinesh GG; Xue W; Safe S; Kamat AM
Apoptosis; 2017 May; 22(5):719-729. PubMed ID: 28283889
[TBL] [Abstract][Full Text] [Related]
2. Novel PKC-ζ to p47 phox interaction is necessary for transformation from blebbishields.
Jinesh GG; Taoka R; Zhang Q; Gorantla S; Kamat AM
Sci Rep; 2016 Apr; 6():23965. PubMed ID: 27040869
[TBL] [Abstract][Full Text] [Related]
3. Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis.
Jinesh GG; Choi W; Shah JB; Lee EK; Willis DL; Kamat AM
Cell Death Differ; 2013 Mar; 20(3):382-95. PubMed ID: 23175184
[TBL] [Abstract][Full Text] [Related]
4. The Blebbishield Emergency Program Overrides Chromosomal Instability and Phagocytosis Checkpoints in Cancer Stem Cells.
Jinesh GG; Kamat AM
Cancer Res; 2017 Nov; 77(22):6144-6156. PubMed ID: 28855211
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis.
Jinesh GG; Molina JR; Huang L; Laing NM; Mills GB; Bar-Eli M; Kamat AM
Cell Death Discov; 2016; 2():16003. PubMed ID: 27551498
[TBL] [Abstract][Full Text] [Related]
6. Endocytosis and serpentine filopodia drive blebbishield-mediated resurrection of apoptotic cancer stem cells.
Jinesh GG; Kamat AM
Cell Death Discov; 2016; 2():15069-. PubMed ID: 27226900
[TBL] [Abstract][Full Text] [Related]
7. Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors.
Kasiappan R; Jutooru I; Mohankumar K; Karki K; Lacey A; Safe S
Mol Cancer Res; 2019 Mar; 17(3):794-805. PubMed ID: 30610105
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.
Lou Z; O'Reilly S; Liang H; Maher VM; Sleight SD; McCormick JJ
Cancer Res; 2005 Feb; 65(3):1007-17. PubMed ID: 15705902
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts.
Zhao Y; Zhang W; Guo Z; Ma F; Wu Y; Bai Y; Gong W; Chen Y; Cheng T; Zhi F; Zhang Y; Wang J; Jiang B
Oncol Rep; 2013 Oct; 30(4):1782-92. PubMed ID: 23877322
[TBL] [Abstract][Full Text] [Related]
10. PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
Meissner M; Stein M; Urbich C; Reisinger K; Suske G; Staels B; Kaufmann R; Gille J
Circ Res; 2004 Feb; 94(3):324-32. PubMed ID: 14684628
[TBL] [Abstract][Full Text] [Related]
11. RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program.
Jinesh GG; Kamat AM
Cell Death Discov; 2017; 3():17023. PubMed ID: 28580172
[TBL] [Abstract][Full Text] [Related]
12. NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression.
Komatsu D; Kato M; Nakayama J; Miyagawa S; Kamata T
Oncogene; 2008 Aug; 27(34):4724-32. PubMed ID: 18454179
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.
Abdelrahim M; Safe S
Mol Pharmacol; 2005 Aug; 68(2):317-29. PubMed ID: 15883203
[TBL] [Abstract][Full Text] [Related]
14. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins.
Higgins KJ; Abdelrahim M; Liu S; Yoon K; Safe S
Biochem Biophys Res Commun; 2006 Jun; 345(1):292-301. PubMed ID: 16678129
[TBL] [Abstract][Full Text] [Related]
15. Blebbishields and mitotic cells exhibit robust macropinocytosis.
Jinesh GG; Kamat AM
Biofactors; 2017 Mar; 43(2):181-186. PubMed ID: 27671897
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells.
Meissner M; Michailidou D; Stein M; Hrgovic I; Kaufmann R; Gille J
Exp Dermatol; 2009 Oct; 18(10):863-9. PubMed ID: 19469899
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor α (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins.
Tu CC; Kumar VB; Day CH; Kuo WW; Yeh SP; Chen RJ; Liao CR; Chen HY; Tsai FJ; Wu WJ; Huang CY
J Mol Endocrinol; 2013; 51(1):203-12. PubMed ID: 23733894
[TBL] [Abstract][Full Text] [Related]
18. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
Loeffler S; Fayard B; Weis J; Weissenberger J
Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
[TBL] [Abstract][Full Text] [Related]
20. Suppression of lung cancer cell invasion by LKB1 is due to the downregulation of tissue factor and vascular endothelial growth factor, partly dependent on SP1.
Liang X; Li ZL; Jiang LL; Guo QQ; Liu MJ; Nan KJ
Int J Oncol; 2014 Jun; 44(6):1989-97. PubMed ID: 24647869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
